Skip to main content

Table 5 Quality appraisal SR/MA

From: Effectiveness and patient safety of platelet aggregation inhibitors in the prevention of cardiovascular disease and ischemic stroke in older adults – a systematic review

Author, year ‘A priori’ Design Duplicate study selection and data extraction Comprehensive literature search performed Status of publication used as an inclusion criterion List of included and excluded studies provided Characteristics of the included studies provided Scientific quality of included studies assessed and documented Scientific quality of included studies used appropriately in formulating conclusions Appropriate methods to combine the findings of studies Assessment of the likelihood of publication bias Conflict of interest stated
Aguilar 2005 [49] u
Aguilar 2007 [30] u
Andersen 2008 [43] n/a
Assiri 2013 [44] u u u
Baignent 2009 [28]
Cameron 2014 [46]
Coleman 2012 [56]
Connolly 2013 [61]
Cooper 2006 [42] u
Dogliotti 2014 [41]
Gandhi 2015 [54] u
Halkes, 2008 [56] n/a n/a
Hart 1999 [39] u
Hart 2007 [40]
He 1998 [29]
Leonardi-Bee 2005 [55] n/a
Lin 2015 [57]
Lip 2006 [45] u
Segal 2000 [38]
Taylor 2001 [37] u u
Warkentin 2012 [57] u   n/a
Zhou 2012 [52]